|
| 36883564 | mTOR inhibition overcomes RSK3-mediated resistance to BET inhibitors in small cell lung cancer. | JCI Insight | 2023 |
| 37029320 | Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance. | Cancer Gene Ther | 2023 |
| 37356470 | Drug combinations identified by high-throughput screening promote cell cycle transition and upregulate Smad pathways in myeloma. | Cancer Lett | 2023 |
| 36926457 | Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs. | ACS Pharmacol Transl Sci | 2023 |
| 34964999 | Conditional deletion of mTOR discloses its essential role in early B-cell development. | Mol Carcinog | 2022 |
| 36369285 | Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice. | Nat Commun | 2022 |
| 33950553 | Fatty acid oxidation is required for embryonic stem cell survival during metabolic stress. | EMBO Rep | 2021 |
| 34876184 | WDR26 and MTF2 are therapeutic targets in multiple myeloma. | J Hematol Oncol | 2021 |
| 32923678 | Mouse tumor susceptibility genes identify drug combinations for multiple myeloma. | J Cancer Metastasis Treat | 2020 |
| 31898340 | Attenuation of immune-mediated bone marrow damage in conventionally housed mice. | Mol Carcinog | 2020 |
| 33066043 | A Small Molecule Stabilizer of the MYC G4-Quadruplex Induces Endoplasmic Reticulum Stress, Senescence and Pyroptosis in Multiple Myeloma. | Cancers (Basel) | 2020 |
| 32747423 | Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis. | Mol Cancer Ther | 2020 |
| 32858886 | Conventional Co-Housing Modulates Murine Gut Microbiota and Hematopoietic Gene Expression. | Int J Mol Sci | 2020 |
| 31061501 | The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription. | Nat Commun | 2019 |
| 31548308 | The transcription factor MZF1 differentially regulates murine <i>Mtor</i> promoter variants linked to tumor susceptibility. | J Biol Chem | 2019 |
| 29255086 | The Reign of Antibodies: A Celebration of and Tribute to Michael Potter and His Homogeneous Immunoglobulin Workshops. | J Immunol | 2018 |
| 30315240 | Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. | Nat Commun | 2018 |
| 29481610 | Characterization of clinically used oral antiseptics as quadruplex-binding ligands. | Nucleic Acids Res | 2018 |
| 28522584 | Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. | Mol Cancer Ther | 2017 |
| 29133782 | mTOR intersects antibody-inducing signals from TACI in marginal zone B cells. | Nat Commun | 2017 |
| 28552607 | cFOS-SOX9 Axis Reprograms Bone Marrow-Derived Mesenchymal Stem Cells into Chondroblastic Osteosarcoma. | Stem Cell Reports | 2017 |
| 26607598 | Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy. | Clin Cancer Res | 2016 |
| 26462961 | Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. | ACS Chem Biol | 2016 |
| 24429254 | TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms. | Mol Oncol | 2014 |
| 25193464 | Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity. | Cancer Lett | 2014 |
| 23357051 | A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses. | J Immunol Methods | 2013 |
| 23858034 | B cell-specific deficiencies in mTOR limit humoral immune responses. | J Immunol | 2013 |
| 23994476 | Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. | Cell Rep | 2013 |
| 22358507 | Mouse genetics 2011: meeting report. | Mamm Genome | 2012 |
| 21252912 | CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression. | Cell Death Differ | 2011 |
| 22053105 | mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells. | Blood | 2011 |
| 21079150 | Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. | Blood | 2011 |
| 19654412 | Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. | Blood | 2009 |
| 15514660 | The Collaborative Cross, a community resource for the genetic analysis of complex traits. | Nat Genet | 2004 |
| 12700664 | p16 INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB. | Oncogene | 2003 |
| 14634638 | The nature and identification of quantitative trait loci: a community's view. | Nat Rev Genet | 2003 |
| 14634209 | Frap, FKBP12 rapamycin-associated protein, is a candidate gene for the plasmacytoma resistance locus Pctr2 and can act as a tumor suppressor gene. | Proc Natl Acad Sci U S A | 2003 |
| 11113205 | Efficiency alleles of the Pctr1 modifier locus for plasmacytoma susceptibility. | Mol Cell Biol | 2001 |
| 10708524 | Structure and localization of mouse Pmscl1 and Pmscl2 genes. | Genomics | 2000 |
| 10663557 | Mapping of the SWAP70 gene to mouse chromosome 7 and human chromosome 11p15. | Immunogenetics | 2000 |
| 10501946 | Mouse chromosome 4. | Mamm Genome | 1999 |
| 10396076 | The role of p16INK4a (Cdkn2a) in mouse plasma cell tumors. | Curr Top Microbiol Immunol | 1999 |
| 9667751 | Multigenic control of skin tumor susceptibility in SENCARA/Pt mice. | Carcinogenesis | 1998 |
| 9482902 | Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. | Proc Natl Acad Sci U S A | 1998 |
| 9662621 | Encyclopedia of the mouse genome VII. Mouse chromosome 4. | Mamm Genome | 1998 |
| 9524251 | Gene organization and chromosome location of the neural-specific RNA binding protein Elavl4. | Gene | 1998 |
| 9354679 | The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. | Blood | 1997 |
| 9209355 | MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia. | Leukemia | 1997 |
| 9233387 | Mouse chromosome 4. | Mamm Genome | 1997 |
| 9328445 | New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin. | Mol Carcinog | 1997 |